Olea building blocks allow vital sign monitoring

  • January 19, 2022
  • Steve Rogerson

Nevada-based Olea Sensor Networks has launched a suite of IoT software and hardware building blocks for developing equipment to monitor vital signs.

The specialist in intelligent sensors and analytic software for sensor network-based systems is offering the digital health platform based on the latest version of OleaSense, a technology system for contactless and remote vital sign monitoring.

The digital health development platform for IoT product development and research features data acquisition systems with multi-sensor development platform capabilities. This suite of software and hardware building blocks can speed time to market with a simpler, more time efficient and more cost-effective method for designing, developing and deploying digital health IoT devices.

The OleaSense software development platforms process real-time data using AI signal processing and peak detection algorithms, extracting vital sign statistics such as cardiac, respiration and heart-rate variability or alternatively the presence or absence of life.

These IoT platforms offer a suite of components featuring: remote data collection from connected devices; independent and secure connectivity between devices; device and sensor analytics; and integration with third-party systems

Using intelligent sensor analytics, the collected data may be transmitted to the cloud for access by professional medical personnel for interpretation and diagnosis. No external wires and no contact with the body is required.

The monitoring device weighs about 0.03kg and is about the size of a business card. It may be slipped into a shirt pocket or worn on a lanyard, or embedded in a chair or mattress. It has been clinically tested and provides medical grade accuracy of resting vital signs. It can also develop an additional feature that provides an individual’s heart signature, which can identify the patient based upon their unique vital sign patterns.

The platform is part of Olea’s portfolio of IoT intellectual property and was developed in such a way that allows a manufacturer to mitigate development cost, increase manufacturing efficiency and accelerate time to market.

“As part of Olea’s intellectual property portfolio offered for licensing to healthcare companies and manufacturers, the OSN digital health platform technology provides a mutual business advantage,” said Frank Morese, CEO of Olea, “which helps them to continue to compete globally and allows them to accelerate their innovations. From start-up to large corporations, companies can benefit from development times being reduced from a typical 36 months to only about six months, thanks to our manufacturing-ready approach to design.”

Olea offers its IP under a variety of licensing models. Users can select the type of licensing that fits their current business plan.

In 2013, Olea launched its flagship product, the OS-3001 intelligent multi-sensor platform for non-clinical R&D use as a handheld or wearable wireless, intelligent, multi-sensor data acquisition platform. It serves as a sensor hub with various on-board intelligent sensors.

Since then, Olea has produced the OS-3005, OS-3008 and 24Ghz OS-3010 platforms for vital sign sensing, the OleaVision life presence detector and heart-signature biometric technology. All are for use with OleaSense sensor-analytics software and, optionally, its cloud-based service using IoT intelligent partitioning architecture.